Skip to main content
. 2018 Sep 19;36:131–139. doi: 10.1016/j.ebiom.2018.09.018

Table 1.

General characteristics of patients with imported uncomplicated falciparum malaria on admission day.

No LFT#
LFT#
p-value
(n = 58) (n = 128)
Age 37 (29–50) 39 (30–47) 0·960
Gender 0·390
Female 18 (31%) 32 (25%)
Male 40 (69%) 96 (75%)
Immunity 0·270
Unknown 3 (5%) 1 (1%)
Non-immune 27 (47%) 57 (45%)
Partially 26 (45%) 65 (51%)
Semi 2 (3%) 5 (4%)
Parasitaemia/μL 7·611 (1·582–44·550) 5·466 (1·146–47·100 0·811
AST (U/L) 21 (17–26) 41 (31–63) <0·001
ALT (U/L) 25 (19–30) 48 (34–68) <0·001
γGT (U/L) 30 (20–37) 71 (49–113) <0·001
Alkaline phosphatase (U/L) 65 (57–79) 83 (64–101) <0·001
Bilirubin (total) (μmol/L) 21 (10–28) 22 (15–31) 0·039
LD (U/L) 275 (196–304) 286 (113–346) 0·181
Haemoglobin (mmol/L) 8·1 (7·4–8·9) 8·7 (7·7–9·4) 0·006
Leukocytes (x109/L) 4·9 (4·0–5·8) 4·9 (3·6–6·4) 0·863
Lymphocytes (x109/L) 0·9 (0·6–1·4) 0·9 (0·6–1·4) 0·998
Thrombocytes (x109/L) 125 (69–174) 87 (56–131) 0·008
CRP (mg/L) 64 (30–116) 106 (56–158) 0·001
Creatinine (μmol/L) 95 (81–108) 95 (81–108) 0·400
Urea (mmol/L) 4·9 (3·9–6·2) 5·2 (4·0–6·4) 0·498
Sodium (mmol/L) 136 (133–138) 135 (133–138) 0·578
Potassium (mmol/L) 3·8 (3·5–4·2) 3·7 (3·5–4·0) 0·299
Lactate (mmol/L) 1·3 (1·0–1·5) 1·4 (1·1–1·9) 0·017
Temperature (°C) 37·6 (36·9–38·8) 38·9 (37·5–39·5) 0·001
Treatment 0·532
atovaquone/proguanil 50 (86%) 108 (84%)
quinine 4 (7%) 4 (3%)
artemether/lumefantrine 4 (7%) 2 (2%)
artesunate 13 (10%)
chloroquine 1 (1%)
Severity LFT# n/a
Mild LFT# n/a 93 (73%)
Moderate LFT# n/a 26 (20%)
Severe LFT# n/a 9 (7%)

All data are presented as median (IQR) or N (%). LFT# = liver function test abnormalities. Statistical differences are tested using Mann-Whitney or Chi square. Clinical laboratory reference ranges can be found in S2 table.